Cagnan, Hayriye
Denison, Timothy
McIntyre, Cameron
Brown, Peter
Funding for this research was provided by:
RCUK | Medical Research Council (MR/R020418/1, MC_UU_12024/1 1188)
Royal Academy of Engineering
U.S. Department of Health & Human Services | National Institutes of Health (R01 NS085188)
Article History
Received: 12 October 2018
Accepted: 26 July 2019
First Online: 2 September 2019
Change Date: 9 September 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.M. is a shareholder in Surgical Information Sciences, Hologram Consultants, Cortics, Autonomic Technologies, Cardionomic and Enspire DBS, as well as a paid consultant to Boston Scientific Neuromodulation. C.M. has intellectual property directly related to the areas we discuss and receives royalties from Neuros Medical, Boston Scientific, Hologram Consultants and Qr8 Health. T.D. is a shareholder in Medtronic, is a consultant for Inspire Medical and Cortec Neurotechnologies, is an advisor for Nia therapeutics, and has intellectual property directly related to the areas we discuss. P.B. has intellectual property directly related to the areas we discuss. H.C. has intellectual property directly related to the areas we discuss.